Net Loss of Tata Chemicals reported to Rs 93.00 crore in the quarter ended December 2025 as against net loss of Rs 53.00 crore during the previous quarter ended December 2024. Sales declined 1.11% to Rs 3550.00 crore in the quarter ended December 2025 as against Rs 3590.00 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales3550.003590.00 -1 OPM %9.7212.09 - PBDT274.00346.00 -21 PBT-19.0066.00 PL NP-93.00-53.00 -75 Powered by Capital Market - Live News

Tata Chemicals will hold a meeting of the Board of Directors of the Company on 2 February 2026.Powered by Capital Market - Live News

Tata Chemicals has allotted 1,50,000 listed, unsecured, rated, redeemable, taxable, non-cumulative non-convertible debentures, having face value Rs 1,00,000/- each, for cash, aggregating to Rs 1,500 crore, for a tenor of 2 years 364 days, to identified investors on private placement basis, on the terms and conditions as mentioned in the transaction documents for the said issue. The NCDs have a fixed rate coupon of 7.06% and have been issued based on multiple yield allotment method. The NCDs will be listed on the Debt Segment of National Stock Exchange of India Limited (NSE). Powered by Capital Market - Live News

Net profit of Tata Chemicals declined 60.31% to Rs 77.00 crore in the quarter ended September 2025 as against Rs 194.00 crore during the previous quarter ended September 2024. Sales declined 3.05% to Rs 3877.00 crore in the quarter ended September 2025 as against Rs 3999.00 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales3877.003999.00 -3 OPM %13.8515.45 - PBDT586.00625.00 -6 PBT301.00348.00 -14 NP77.00194.00 -60 Powered by Capital Market - Live News

Tata Chemicals will hold a meeting of the Board of Directors of the Company on 1 November 2025.Powered by Capital Market - Live News